3Leino A. lmpivaara O. Health-based reference intervals for ALAT,ALST and GT in serum, measured according to the reeommendationgs of the ECCLS[J]. Seand J Clin Lah Invest . 1995,55(33):243.
2Goessling W, Massaro J, Vasan R D, et al.Aminotransferase levels and 20-years risk of metabolic syndrome, diabetes, and cardiovascular disease[J].Gastroenterology, 2008, 134 ( 15 ) : 1935- 1944.
3Uto H, Stuver S, Hayashi K, et al.Increased rate ofdeath related to presence of viremia among hepatitis C virus antibody positive subjects in a community-based cohort study[J].Hepatology, 2009, 50 ( 14 ) : 393-399.
4Lee T K, Benson J, Themeau T, et al.Serum aminotranferase activity and mortality risk in a United States eommunity[J].Hepatology, 2008, 47 ( 45 ) : 880-887.
